0001279569-19-001666.txt : 20190805 0001279569-19-001666.hdr.sgml : 20190805 20190805103656 ACCESSION NUMBER: 0001279569-19-001666 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190805 FILED AS OF DATE: 20190805 DATE AS OF CHANGE: 20190805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEOVASC INC CENTRAL INDEX KEY: 0001399708 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36458 FILM NUMBER: 19997836 BUSINESS ADDRESS: STREET 1: 2135 13700 Mayfield place CITY: RICHMOND STATE: A1 ZIP: 00000 BUSINESS PHONE: 604-270-4344 MAIL ADDRESS: STREET 1: 2135 13700 Mayfield place CITY: RICHMOND STATE: A1 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Medical Ventures Corp DATE OF NAME CHANGE: 20070516 6-K 1 neovasc6k.htm FORM 6-K
 

 

Securities and Exchange Commission

washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

 

 

 

For the month of

 August   2019

 

Commission File Number

 001-36458    

 

Neovasc Inc.

(Translation of registrant’s name into English)

 

Suite 5138 - 13562 Maycrest Way

Richmond, British Columbia, Canada, V6V 2J7

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

 

Form 20-F

 ☒

 

Form 40-F

  ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):          

 

            Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):           

 

 

 

 

 
 
 

 

DOCUMENTS INCLUDED AS PART OF THIS REPORT

 

 

Document    
     
Document 1   News Release dated August 5, 2019 - Neovasc to Attend Canaccord Genuity 39th Annual Growth Conference
     

 

 
 

DOCUMENT 1

 

 

 

Neovasc to Attend Canaccord Genuity 39th Annual Growth Conference

Presentation Scheduled for 11:30 am Eastern Time on August 8th

NASDAQ, TSX: NVCN

VANCOUVER, Aug. 5, 2019 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that Fred Colen, Chief Executive Officer, will present a corporate overview at the Canaccord Genuity 39th Annual Growth Conference, being held August 7-8, 2019 in Boston, Massachusetts.

Presentation Details:

Date: Thursday, August 8
Time: 11:30am Eastern Time
Webcast: http://wsw.com/webcast/canaccord35/nvcn/

 

About Neovasc Inc.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ (the "Reducer"), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara™, for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada and Europe. For more information, visit: www.neovasc.com.

View original content:http://www.prnewswire.com/news-releases/neovasc-to-attend-canaccord-genuity-39th-annual-growth-conference-300895468.html

SOURCE Neovasc Inc.

View original content: http://www.newswire.ca/en/releases/archive/August2019/05/c2409.html

%CIK: 0001399708

For further information: Chris Clark, Chief Financial Officer, Neovasc Inc., 604 248-4138, cclark@neovasc.com; Jeremy Feffer, LifeSci Advisors, LLC, 212-915-2568

CO: Neovasc Inc.

CNW 08:55e 05-AUG-19

 

 
 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Neovasc Inc.
  (Registrant)

 

Date:

  

 

August 5, 2019

 

 

 

By:

 

/s/ Chris Clark

 

Name: Chris Clark

Title: Chief Financial Officer

 

           

 

 

 GRAPHIC 2 image_001.jpg GRAPHIC begin 644 image_001.jpg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end